Page last updated: 2024-10-20

spermidine and Cardiometabolic Syndrome

spermidine has been researched along with Cardiometabolic Syndrome in 1 studies

Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Madeo, F1
Eisenberg, T1
Pietrocola, F1
Kroemer, G1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Autophagy Characterization and Multi-level Molecular Profiling of Spermidine Supplementation: a Clinical Study[NCT04823806]80 participants (Anticipated)Interventional2020-12-01Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for spermidine and Cardiometabolic Syndrome

ArticleYear
Spermidine in health and disease.
    Science (New York, N.Y.), 2018, Jan-26, Volume: 359, Issue:6374

    Topics: Aging; Animals; Anti-Inflammatory Agents, Non-Steroidal; Autophagy; Biological Transport; Caloric Re

2018